The Melatonin Derivative ITH13001 Prevents Hypertension and Cardiovascular Alterations in Angiotensin II-Infused MiceSJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82024-02-012OAAI
Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 PathwaySCIENTIFIC REPORTSIF3.92019-11-1122OAAI
Egg White Hydrolysate: A new putative agent to prevent vascular dysfunction in rats following long-term exposure to aluminumFOOD AND CHEMICAL TOXICOLOGYIF3.52019-11-0117PREAI
Egg white hydrolysates improve vascular damage in obese Zucker rats by its antioxidant propertiesJOURNAL OF FOOD BIOCHEMISTRYIF4.22019-10-017OAAI
Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: A concerted action of NAD(P)H oxidase and COX-2TOXICOLOGYIF4.62017-09-0135PREAI
Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertensionBRITISH JOURNAL OF PHARMACOLOGYIF7.72015-04-10136OAAI
Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathwaysTOXICOLOGY AND APPLIED PHARMACOLOGYIF3.42013-04-0151PRE
Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular functionBRITISH JOURNAL OF PHARMACOLOGYIF7.72012-05-1725OAAI
Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stressJOURNAL OF HYPERTENSIONIF4.12012-02-0152PREAI
ANGIOTENSIN-II- INDUCED ENDOTHELIN-1 PRODUCTION CONTRIBUTES TO THE INCREASED COX-2 EXPRESSION IN HYPERTENSIVE RATS. ROLE OF PPARJOURNAL OF HYPERTENSIONIF4.12010-06-010OAAI
Ouabain treatment increases nitric oxide bioavailability and decreases superoxide anion production in cerebral vesselsJOURNAL OF HYPERTENSIONIF4.12008-10-0111OAAI